Bicycle Therapeutics Plc (BCYC)
7.09
-0.31
(-4.19%)
USD |
NASDAQ |
Dec 09, 16:00
7.10
+0.01
(+0.14%)
After-Hours: 20:00
Bicycle Therapeutics EPS Diluted (Quarterly): -0.8476 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
| Mereo BioPharma Group Plc | -0.0436 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.75M |
| Revenue (Quarterly) | 11.66M |
| Total Expenses (Quarterly) | 70.41M |
| Enterprise Value | -150.02M |
| Gross Profit Margin (Quarterly) | 85.04% |
| Profit Margin (Quarterly) | -503.7% |
| Earnings Yield | -51.15% |
| Normalized Earnings Yield | -51.78 |